In what may be one of the most important HIV research breakthroughs in years, scientists have discovered a strikingly ...

What if the presence of a well-known but misunderstood viral protein explains why some people living with HIV (PLWH) never ...

Data from the CLARITY study will provide insights on acceptability and tolerability of single-dose cabotegravir and lenacapavir long-acting injections Four-year analysis from the OPERA cohort ...

What if the presence of a well-known but misunderstood viral protein explains why some people living with HIV (PLWH) never ...

Researchers showed that people treated with fostemsavir have lower levels of “bad” antibodies produced in response to a HIV ...

What if the presence of a well-known but misunderstood viral protein explains why some people living with HIV (PLWH) never ...

The Nobel Prize in Physiology or Medicine 2025 has been awarded to 3 researchers for the discovery and characterization of ...

Hodgkin lymphoma and other malignancies that express the CD30 protein have been the scourge of oncologists for decades. For ...

What if the presence of a well-known but misunderstood viral protein explains why some people living with HIV (PLWH) never recover their health, even ...

Johns Hopkins scientists discovered a way to convert “immune-cold” tumors into “immune-hot” ones by activating key immune ...

This year's prize recognized what the committee described as fundamental discoveries that launched the field of peripheral immune tolerance.

Researchers have identified how to encourage tumors to build their own immune hubs—structures that look and function like ...